MICHAEL E. POLLACK, MD

Plain English
This study looked at how well stroke survivors received discharge information after leaving the hospital and if it matched what they wanted. Out of 1,161 patients, only 35% finished the survey, revealing that while over 80% wanted specific information, only 28% received all the information they preferred. This is crucial because better communication can help improve recovery and support for stroke survivors. Who this helps: This helps stroke survivors and their families.

Plain English
This study compared two combination medications for patients with moderate to very severe chronic obstructive pulmonary disease (COPD) to see which one offers better value for money while reducing the risk of death. Researchers found that the medication BGF costs less and improves life quality more than FF/UMEC/VI, saving about £7 per patient in the first year and £23 in the fifth year, while also allowing patients to live longer. This is important because it shows that BGF not only helps patients live healthier lives but also reduces overall healthcare costs. Who this helps: This helps patients with COPD and the healthcare system in the UK.

Plain English
This study explored the role of linoleic acid (LA), a common dietary fat, in severe infections (sepsis) and kidney damage in critically ill children. It found that higher levels of LA were linked to a specific severe form of sepsis (phenotype D), with an odds ratio of 1.67, and increased chances of acute kidney injury (AKI), with an odds ratio of 1.52 for LA-derived compounds. Understanding this connection can help medical professionals target treatment for children with severe infections and kidney issues. Who this helps: This helps doctors and healthcare providers in treating critically ill children with sepsis.

Plain English
This study looked at how the drug clopidogrel affects recovery in older mice after a stroke. Researchers found that mice treated with clopidogrel had lower survival rates (only 40% survived compared to 80% of those not treated), lost more weight, and showed increased levels of a harmful protein called amyloid beta in their brains. These findings are important because they suggest that clopidogrel might make recovery harder for older stroke patients by interfering with brain repair processes. Who this helps: This study helps older stroke patients and their doctors understand the potential risks of clopidogrel.

Plain English
This study looked at the effectiveness of a single inhaler treatment for chronic obstructive pulmonary disease (COPD) called budesonide/glycopyrrolate/formoterol fumarate (BGF) compared to multiple inhaler treatments. It found that patients using BGF had an 18% lower risk of dying from any cause and a 12% lower risk of experiencing a severe lung-related event than those using multiple inhalers. This matters because it suggests that using a single inhaler could be a more effective way to manage COPD and improve patient outcomes. Who this helps: This helps COPD patients seeking better treatment options.

Plain English
This study looked at what activities knee surgery patients hoped to do after their operations and how satisfied they were with achieving those goals three months later. Researchers found that while a lot of patients (43%) cared about returning to sports and recreation, they were more likely to be satisfied with completing lower-impact activities, such as household tasks and hobbies, with a satisfaction rate of 67%. Meeting these activity goals was closely linked to overall happiness with the surgery results, meaning that understanding what individual patients want to achieve is crucial for their satisfaction. Who this helps: This helps patients undergoing knee surgery by aligning their expectations with realistic post-surgery goals.

Plain English
This study looked at how various factors related to a person's life and health (like physical condition, mental state, and lifestyle) can help predict how well they will recover after knee surgery. By analyzing data from 863 patients, researchers created models that forecasted improvements in quality of life and knee symptoms a few months after surgery. They found that factors such as pre-surgery health scores, nutrition, and expectations about pain significantly influenced recovery outcomes. Who this helps: This benefits patients undergoing knee surgery by providing more tailored care plans that consider their overall well-being.

Plain English
The AURA study looked at patients in Spain who started a specific inhaler treatment for chronic obstructive pulmonary disease (COPD) called budesonide/glycopyrronium/formoterol. Out of 482 patients, the average age was about 71, and nearly 57% had at least one serious flare-up of their condition in the previous year, with 12.7% needing hospital care. This is important because it highlights that many patients have advanced stages of COPD and multiple health issues, showing a high need for effective treatment options. Who this helps: This helps patients with COPD and their doctors by providing insights into treatment needs and outcomes.

Plain English
This study evaluated a new program aimed at improving care for patients with high-risk chronic obstructive pulmonary disease (COPD) compared to regular treatment. Researchers looked at 126 groups of primary care patients in the UK and US, focusing on those who had experienced multiple COPD flare-ups. They will measure the number of flare-ups and serious health events over two years to see if the new program is more effective than standard care. Who this helps: This helps patients with modifiable high-risk COPD who need better management of their condition.

Plain English
This research looked at how flare-ups of Chronic Obstructive Pulmonary Disease (COPD) affect the risk of serious heart problems. It involved over 1 million people and found that after a COPD exacerbation, the risk of complications like heart attacks and strokes is significantly higher. For example, during the first week after an exacerbation, the risk was more than 10 times greater, and even after a year, it was still nearly 50% higher compared to those who hadn't had an exacerbation. Who this helps: This information benefits patients with COPD and their doctors by highlighting the need for careful cardiovascular monitoring after flare-ups.

Plain English
This study examined the safety and effects of a new drug called RE104, which is a type of psychedelic. Researchers gave single doses of RE104 (ranging from 5 to 40 mg) to 48 healthy adults and found it to be generally safe, with no serious side effects and only mild to moderate reactions. The drug produced a psychoactive experience lasting about 3 to 4 hours, showing potential for future therapeutic use. Who this helps: This research benefits future patients looking for new treatments, especially those with mental health conditions.

Plain English
This study looked at how quickly patients with chronic obstructive pulmonary disease (COPD) started a specific inhaler treatment (BGF) after experiencing a worsening of their condition. It found that patients who began using this inhaler within 30 days had a 25.7% lower risk of future COPD flare-ups compared to those who started later, and a 16.3% lower risk of heart and lung-related health issues. Starting treatment quickly matters because it can lead to better health outcomes and fewer complications for these patients. Who this helps: Patients with COPD and their doctors.

Plain English
This study examined the connection between the Epstein-Barr virus (EBV) and the risk of death in children suffering from sepsis, analyzing data from 320 patients. The researchers found that about 54% of the children had EBV present and that this was directly linked to higher death rates—172 children had a causal association with mortality, particularly through specific immune responses. This research is important because it highlights that EBV could worsen immune problems in sepsis patients, potentially leading to higher mortality rates. Who this helps: This helps doctors and healthcare providers in understanding risks for children with sepsis.

Plain English
This study looked at patients in the U.S. who were hospitalized for worsening chronic obstructive pulmonary disease (COPD) and what happened to them after they left the hospital. They found that within a year, 34.6% of patients had serious issues related to their lungs or heart, 16.7% were readmitted to the hospital, and 18.2% died. Many patients were not prescribed proper treatment upon leaving, which indicates a need to improve how COPD is managed after hospitalization. Who this helps: This helps patients with COPD and their healthcare providers.

Plain English
This study looked at the lungs of 31 donor bodies to understand how different lung issues and anatomical differences could affect surgeries like lung removals. The researchers found that 12.9% of the lungs had cancer, and 17.7% showed significant scarring or collapse. Interestingly, they observed that larger tumors tended to be associated with lower quality fissures in the lungs. Who this helps: This information benefits doctors and surgeons by informing better planning for lung surgeries.

Plain English
This study aims to create and test an online educational program to help patients better understand what to expect from total knee replacement surgery. Researchers will focus on whether this program can help modify patients' expectations, improve their satisfaction after surgery, and help them set realistic recovery goals. The study will include 150 patients, and the goal is to see how well the educational program works compared to traditional pre-surgery education. Who this helps: This helps patients preparing for total knee replacement surgery.

Plain English
This study looked at how quickly patients with chronic obstructive pulmonary disease (COPD) started treatment with a specific inhaler (budesonide/glycopyrrolate/formoterol fumarate) after experiencing an exacerbation. Researchers found that patients who started treatment within 30 days had a lower rate of subsequent COPD flare-ups—1.66 flare-ups per year—compared to those who started later (2.36 for delayed and 2.60 for very delayed). This matters because starting treatment quickly can help prevent worsening of COPD and improve patients' health. Who this helps: Patients with COPD.

Plain English
This study looked at how stroke survivors use their affected arm in daily activities compared to healthy people. Researchers used two methods to gather data: one involved monitoring arm movement with accelerometers, and the other involved asking participants about their daily experiences through prompts. They found that stroke survivors used their affected arm much less—showing a 70% lower use—compared to healthy individuals, and also reported feeling less skilled and facing more challenges with that arm. This research is important because it highlights how personal experiences and environmental situations influence arm use, which can help shape better rehabilitation strategies for stroke recovery. Who this helps: This benefits stroke survivors and their rehabilitation teams.

Plain English
This study looked at the ways the radial artery, a key blood vessel in the arm, can vary in where it branches from the main artery in a specific group of Midwestern cadavers. Researchers found that in 11.5% of cases, the radial artery originated higher up than normal, which could affect medical procedures that involve this artery. This information is important for doctors to know because it can improve the safety and effectiveness of surgeries and treatments in the arm. Who this helps: This helps doctors and surgeons performing procedures on the arm.

Plain English
This study focused on patients with certain types of rare cancers caused by neurotrophic tyrosine receptor kinase (NTRK) gene fusions, which occur in less than half a percent of common tumors. Researchers gathered information from various medical databases and hospital records, identifying 512 patients with these gene fusions. This is important because it creates a larger pool of real-world data that can help develop targeted treatments for patients with these specific genetic changes in their tumors. Who this helps: This helps patients with rare cancers, their doctors, and researchers working on targeted therapies.

Plain English
The study focused on improving the care of patients with Chronic Obstructive Pulmonary Disease (COPD) through a quality improvement program called CONQUEST in three integrated healthcare systems. The research outlined three key stages: developing the program, preparing healthcare systems for its implementation, and executing the program. It found that strong local leadership and thorough preparation are vital for successful implementation, emphasizing that adaptable models tailored to specific healthcare resources enhance patient care. Who this helps: This benefits patients with COPD, doctors, and healthcare systems looking to improve chronic disease management.

Plain English
This study examined the health risks faced by stroke survivors living in the community, focusing on factors like diet, exercise, alcohol use, smoking, and mental health. Researchers found two main groups: 16% of participants had poor mental health and unhealthy habits, while 84% had risky alcohol use but better physical health. These findings are important because they highlight the need for tailored support and interventions for stroke survivors based on their specific health profiles. Who this helps: This helps stroke survivors and healthcare providers by informing better care practices.

Plain English
This study looked at how long patients stayed in a rehabilitation hospital and how well they recovered after being referred to the National Disability Insurance Scheme (NDIS) between 2017 and 2021. Researchers found that patients referred to the NDIS stayed in the hospital longer than expected—on average, their stays were greater than necessary, costing extra time and resources. Additionally, the efficiency of their recovery was lower compared to patients who weren’t referred to the NDIS, which shows that the process of getting NDIS support may still be creating delays in patient care. Who this helps: This helps patients needing rehabilitation and healthcare providers managing their recovery.

Plain English
This study looked at how a web-based tool called EnableMe can help people who have had a stroke or a transient ischemic attack (TIA) after they leave the hospital. Researchers found that those who used EnableMe reported a better quality of life, had lower depression scores, and faced fewer unmet needs than those who received usual care; specifically, there was a significant improvement in quality of life for users at three months. This matters because it shows that providing online support can make a real difference in recovery for stroke survivors. Who this helps: This helps stroke survivors and their caregivers.

Plain English
This study looked at the role of a protein called neuropeptide Y (NPY) in how adults who experienced trauma as children handle their emotions and mental health problems. The researchers found that among 54 adult trauma survivors, those with higher levels of NPY were less likely to struggle with mental health issues related to emotion regulation. Specifically, for every increase in NPY, the negative impact of emotional struggles on mental health was reduced. Who this helps: This helps trauma survivors by potentially identifying a biological pathway that could aid in their recovery.

Plain English
The study looked at how patients with intermittent or mild persistent asthma fill their prescriptions for rescue and long-term medications around serious asthma attacks that require urgent care or hospitalization. Out of over 323,000 patients, about 16% experienced a serious exacerbation. The researchers found that before the exacerbation, patients were more likely to fill rescue medications (25% compared to 19% for maintenance drugs), but after the exacerbation, nearly 89% filled maintenance prescriptions, indicating that there may be an important time to change their treatment to prevent future attacks. Who this helps: This helps asthma patients, especially those with mild persistent conditions, improve their care and prevent serious episodes.

Plain English
This study explored how people in Australia with different health conditions experience barriers and support when trying to access rehabilitation services. Out of the 56 participants, many shared that issues like limited options and feeling responsible for their access made it harder to get the help they needed. The findings highlight the importance of providing better information and a supportive environment to help patients make informed decisions about their rehabilitation. Who this helps: This benefits patients seeking rehabilitation services.

Plain English
This study explored how healthcare professionals in Australia view the challenges and opportunities of accessing rehabilitation services. Researchers interviewed 31 different professionals and found three major issues: confusion about what rehabilitation means, delays in getting necessary patient information, and a lack of understanding of the diverse needs of patients. These findings highlight the need for improved communication and better systems to ensure patients get the rehabilitation care they need. Who this helps: This benefits patients who require rehabilitation services.

Plain English
This study looked at how breathing during exercise spreads air and tiny particles, which can carry viruses. Researchers tested 12 people exercising while wearing no mask, a surgical mask, or an FFP2 mask. They found that both masks significantly reduced the spread of particles: surgical masks cut emissions by 87%, and FFP2 masks reduced them by 91%. Notably, FFP2 masks also reduced smaller particles that stay in the air longer. This matters because it shows that wearing these masks can help reduce the risk of spreading respiratory infections during exercise. Who this helps: This helps people exercising in gyms and fitness centers, as well as their trainers and health professionals.

Plain English
The AURA study looked at patients with chronic obstructive pulmonary disease (COPD) who started using a new inhaler treatment called budesonide/glycopyrrolate/formoterol (BGF) after it was approved in 2020. It found that out of over 30,000 patients, 57.9% had experienced serious COPD symptoms in the year before starting BGF, and many had other health issues, like heart disease and high blood pressure. This information is important because it helps doctors understand the types of patients using this treatment and highlights the ongoing struggles they face with their COPD despite previous therapies. Who this helps: This helps doctors and healthcare providers who treat patients with COPD.

Plain English
This study looked at asthma patients who experienced severe attacks, requiring medical attention, to see how their medication use changed before and after these episodes. The researchers found that 27.2% of children and 16.8% of adults experienced at least one serious asthma attack, and while many were using rescue inhalers (SABA) before the attacks, a significant number (about 40%) weren't using long-term control medications (like inhaled corticosteroids) to manage their asthma. This lack of proper maintenance therapy before an exacerbation suggests there’s a missed opportunity to prevent severe attacks by starting anti-inflammatory medications sooner. Who this helps: This helps asthma patients and their doctors by highlighting the need for better management strategies.

Plain English
The study looked at how many immunocompromised people were affected by COVID-19 and the costs associated with their treatment. Out of over 16 million patients, about 458,000 (or 2.7%) were immunocompromised. These individuals experienced a COVID-19 incidence rate of 101.3 cases per 1,000 each year, with those suffering from end-stage renal disease being the most affected, and hospitalizations for COVID-19 cost nearly $1 billion for the group, averaging $64,029 per patient. This research highlights the significant risk and financial burden of COVID-19 on immunocompromised individuals, emphasizing the need for better prevention strategies. Who this helps: This helps patients with weakened immune systems and their healthcare providers.

Plain English
This study looked at how the medication clopidogrel affects brain recovery after a stroke in mice. The researchers found that mice treated with clopidogrel had worse learning and memory abilities, lower survival rates, and lost weight compared to those that weren't given the drug. Clopidogrel also caused more leakage in blood vessels and disrupted brain cell activity crucial for repair after injury. Who this helps: This information benefits doctors and researchers working with stroke survivors.

Plain English
This study looked at how patients with high-risk chronic obstructive pulmonary disease (COPD) were managed in the United States from 2011 to 2019. It found that in 2019, 10% of patients were classified as high-risk, but many did not receive proper diagnostic tests or treatment: 81% of newly diagnosed patients hadn't had a lung function test, and 52% didn't have any prescription for COPD medications. These findings highlight significant gaps in care, suggesting that more needs to be done to follow guidelines and provide better support for these patients. Who this helps: This research benefits patients with COPD and their healthcare providers by identifying areas for improvement in their care.

Plain English
This study looked at how a patient's psychological and social situation before knee surgery affects their recovery after the surgery. The researchers collected information from 1,050 patients, which included details about their mental health, social support, and physical condition, and they aim to create a tool that predicts how well each patient will recover based on this information. This is important because it could help doctors provide better-tailored rehabilitation plans, improving outcomes for patients after total knee replacements. Who this helps: This benefits patients undergoing knee surgery and their doctors by improving recovery strategies.

Plain English
This study looked at how quickly patients with chronic obstructive pulmonary disease (COPD) started a new treatment called budesonide/glycopyrrolate/formoterol fumarate (BGF) after experiencing a worsening of their condition, known as an exacerbation. It found that those who started BGF within 30 days had fewer subsequent flare-ups (1.52 on average) compared to those who started later (2.00 for 31-180 days and 2.30 for 181-365 days). Additionally, starting BGF promptly led to lower health-related costs, averaging $5,002 compared to $7,639 and $8,724 for delayed and very delayed groups, respectively. Who this helps: This benefits patients with COPD by reducing their risk of further complications and lowering treatment costs.

Plain English
This study focused on improving arm rehabilitation for stroke survivors by establishing a national partnership that connects therapists, researchers, and healthcare providers. The goal was to provide a new therapy called SENSe therapy in specialized centers to help stroke patients regain movement and improve their quality of life. If successful, this approach could lead to better recovery outcomes for patients and might be applied to other types of rehabilitation in the future. Who this helps: This benefits stroke survivors and their therapists.

Plain English
This study looked at patients with chronic obstructive pulmonary disease (COPD) who started a specific combination treatment (triple therapy) after experiencing disease flare-ups. Researchers found that starting this treatment promptly within 30 days reduced the chances of having more flare-ups and lowered healthcare costs. Specifically, each 30-day delay in starting the therapy led to an 11% higher risk of any flare-up and a 7% higher risk of severe flare-ups, along with increased costs associated with their care. Who this helps: Patients with COPD benefit from quicker treatment to manage their condition better and reduce costs.

Plain English
This study looked at how the severity and frequency of COPD flare-ups affect future health issues and costs for Medicare patients. It found that nearly 40% of patients had at least one moderate or severe flare-up in the first year. Those with multiple flare-ups were 2 to 4 times more likely to have additional issues in the following two years, with healthcare costs increasing by up to $2,117 compared to those with no flare-ups. Who this helps: This helps Medicare patients with COPD and their healthcare providers.

Plain English
This research looked at how an online program called Prevent 2nd Stroke (P2S) could improve the quality of life for stroke survivors after six months. The study found that participants using the P2S program reported a higher quality of life score of 85 compared to 80 for those who received standard health website links. This is important because better quality of life can lead to improved overall well-being for stroke survivors. Who this helps: This benefits stroke survivors looking for tools to enhance their health and well-being after their condition.

Plain English
This research study is looking into whether a specific type of medication, called P2Y12 receptor inhibitors, given after a stroke, affects the chance of developing cognitive disorders or dementia. It will analyze data from Swedish health records of stroke patients from 2006 to 2016, expecting to determine the impact of these medications over 1, 2, and 5 years. The results matter because understanding this link can help healthcare providers make better treatment decisions for stroke survivors, potentially protecting their cognitive health. Who this helps: Patients who have had a stroke.

Plain English
The study looked at the real-life impact of systemic lupus erythematosus (SLE), an autoimmune disease, on patients in the U.S. from 2016 to 2018. It found that about 490,000 adults have SLE, with a higher prevalence among people in the South, African-American individuals, and women. SLE patients experience significantly worse quality of life, reporting physical limitations and higher rates of depression and pain-related work issues, along with much higher healthcare costs ($17,270 compared to $8,350 for non-SLE patients). Who this helps: This helps patients with SLE and their healthcare providers understand the disease's wider impact.

Plain English
This study looked at how stroke survivors with minor disabilities use the internet and social media. It found that 79% of the 354 participants used the internet daily, while 41% accessed social media daily, and 46% searched for health information at least monthly. The research is important because it shows that the internet can be a helpful tool for reaching out to stroke survivors who are at risk of having another stroke, even if they are not severely disabled. Who this helps: Patients and healthcare providers involved in stroke recovery and prevention.

Plain English
This study looked at the use of short-acting bronchodilators in patients with asthma and how this relates to costs and severe asthma attacks. Researchers analyzed over 1 million patients and found that half were using basic asthma treatments (GINA Step 1), but many experienced severe exacerbations—about 0.95 incidents per patient overall. The average healthcare cost for asthma patients was about $7,148 per year, highlighting that more frequent bronchodilator use was linked to increased costs and attacks. Who this helps: This research can benefit asthma patients and their doctors by identifying the need for better treatment options.

Plain English
This study examined how the National Cancer Institute (NCI) has partnered with the life sciences and pharmaceutical industries, showing that these connections are important for both new and established companies. Researchers found that early-stage companies that collaborated with the NCI had a strong chance of financial success, and this support also extended to the 20 largest pharmaceutical companies. Understanding these partnerships is crucial because they can lead to better cancer treatments and innovations in healthcare. Who this helps: Patients and doctors seeking advanced cancer therapies.

Plain English
This study looked at how often newly diagnosed Medicare patients with chronic obstructive pulmonary disease (COPD) use oral corticosteroids (OCS) and the health problems they face. It found that 36% of these patients received OCS within four years of their diagnosis, with 38% using it longer than the recommended 5-7 days. Furthermore, patients who received over 1000 mg of OCS were more likely to develop new health issues, such as heart disease and obesity, compared to those who did not use OCS. Who this helps: This information benefits patients with COPD and their doctors by highlighting the risks associated with certain treatments.

Plain English
This study looked at how quickly patients with chronic obstructive pulmonary disease (COPD) start a specific triple therapy after being hospitalized for a severe worsening of their condition. The researchers found that if patients delayed starting the therapy, their chances of having another exacerbation increased by 13% for each 30-day delay, leading to more health care costs and care needs. This is important because it shows that starting treatment quickly can help prevent further health issues and reduce costs for both patients and the healthcare system. Who this helps: This benefits patients with COPD and their doctors.

Plain English
This study focused on developing a telehealth exercise program specifically designed for people who have had a stroke. Researchers created a structured four-stage process involving 11 team members and 32 individuals with relevant experience to develop the program, highlighting key improvements like more training for therapists and personalized options for patients. This matters because it ensures that the intervention is better tailored to the needs of stroke survivors, making it more effective for them. Who this helps: This helps stroke survivors and healthcare professionals involved in their recovery.